NYSE: TDOC · Industrial Applications and Services · 5 alerts · CIK 1477449
Share price
$8.70Close, Nov 16
Market cap
$1.59B
Shares outstanding
182.29MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Services-Offices & Clinics of Doctors of MedicineSIC 8011
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Teladoc Health, Inc. filings on SEC EDGAR ↗
Teladoc Health President, International Carlos Nueno Sells $271K of Stock
Carlos Nueno, President, International, sold 29,432 shares of Teladoc Health, Inc. at $9.20 a share, worth $271K in total on Nov 6, 2026. Shares held after the trade: 35,312 (-45.5%).
Teladoc Health reported a revenue decrease to $605.1 million for the third quarter of 2026 compared to $626.4 million in the prior year period. The company's net loss narrowed to $26.9 million, or $0.15 per share, while cash and cash equivalents increased to $849.9 million as of September 30, 2026.
Teladoc Health reported third quarter 2026 revenue of $605.1 million, a 3% decrease year-over-year, driven by a 13% decline in its BetterHelp segment. The company narrowed its net loss to $26.9 million ($0.15 per share) compared to $49.5 million in the prior year, while adjusted EBITDA grew 14% to $79.4 million.
Term
Q3 2026
“We delivered third quarter results near the upper end of our guidance range for consolidated revenue and above our range for consolidated adjusted EBITDA, reflecting solid execution across our two segments.”
Chuck Divita, Chief Executive Officer of Teladoc Health
“Within the Integrated Care segment, we continue to advance our innovation agenda, including the implementation of Teladoc One with our early launch partners, while also expanding our capabilities through initiatives such as hybrid care and AI-enabled solutions.”
Chuck Divita, Chief Executive Officer of Teladoc Health
Adam C. Vandervoort, Chief Legal Officer and Secretary, has resigned effective November 1, 2026, citing 'good reason' under his severance agreement. He will be succeeded by Jonathan Dorfman, the current SVP of Securities & Corporate Law, while Vandervoort provides unpaid advisory services through November 2027 to assist with the transition.
Teladoc Health CEO Charles Divita III Sells $109K of Stock
Charles Divita III, CEO, sold 17,805 shares of Teladoc Health, Inc. at $6.10 a share, worth $109K in total on Sep 11, 2026. Shares held after the trade: 465,535 (-3.7%).